Efficacy of BRAF Inhibitors in Asian Metastatic Melanoma Patients: Potential Implications of Genomic Sequencing in BRAF-Mutated Melanoma()()

BACKGROUND: The BRAF inhibitors vemurafenib and dabrafenib are currently the standard treatment for metastatic melanoma with BRAF V600 mutations. However, given the rarity of noncutaneous melanoma, including acral and mucosal subtypes, the efficacy of BRAF inhibitors for this subset of patients has...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Transl Oncol
Main Authors: Kim, Hee Kyung, Lee, Sunyoung, Kim, Kyung, Heo, Mi Hwa, Lee, Hansang, Cho, Jinhyun, Kim, Nayoung K.D., Park, Woongyang, Lee, Su Jin, Kim, Jung Han, Jang, Kee-Taek, Choi, Sang-Hee, Lee, Jeeyun
Formato: Artigo
Idioma:Inglês
Publicado: Neoplasia Press 2016
Assuntos:
Original article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC5122709/
https://ncbi.nlm.nih.gov/pubmed/27883956
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.tranon.2016.09.004
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares